186 related articles for article (PubMed ID: 10555639)
21. Effect of hypoxia on enterocyte endocytosis of enteric bacteria.
Wells CL; VandeWesterlo EM; Jechorek RP; Erlandsen SL
Crit Care Med; 1996 Jun; 24(6):985-91. PubMed ID: 8681603
[TBL] [Abstract][Full Text] [Related]
22. Attenuation of Clostridium difficile toxin-induced damage to epithelial barrier by ecto-5'-nucleotidase (CD73) and adenosine receptor signaling.
Schenck LP; Hirota SA; Hirota CL; Boasquevisque P; Tulk SE; Li Y; Wadhwani A; Doktorchik CT; Macnaughton WK; Beck PL; MacDonald JA
Neurogastroenterol Motil; 2013 Jun; 25(6):e441-53. PubMed ID: 23600886
[TBL] [Abstract][Full Text] [Related]
23. Transforming Growth Factor β1/SMAD Signaling Pathway Activation Protects the Intestinal Epithelium from Clostridium difficile Toxin A-Induced Damage.
Tinoco-Veras CM; Santos AAQA; Stipursky J; Meloni M; Araujo APB; Foschetti DA; López-Ureña D; Quesada-Gómez C; Leitão RFC; Gomes FCA; Brito GAC
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784928
[No Abstract] [Full Text] [Related]
24. Clostridium difficile toxin B disrupts the barrier function of T84 monolayers.
Hecht G; Koutsouris A; Pothoulakis C; LaMont JT; Madara JL
Gastroenterology; 1992 Feb; 102(2):416-23. PubMed ID: 1732112
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of varying concentrations of clostridium difficile toxin A on epithelial barrier function and expression of cytokines.
Johal SS; Solomon K; Dodson S; Borriello SP; Mahida YR
J Infect Dis; 2004 Jun; 189(11):2110-9. PubMed ID: 15143480
[TBL] [Abstract][Full Text] [Related]
26. Exogenous phosphatidylcholine supplementation improves intestinal barrier defense against Clostridium difficile toxin.
Olson A; Diebel LN; Liberati DM
J Trauma Acute Care Surg; 2014 Oct; 77(4):570-5; discussion 576. PubMed ID: 25250596
[TBL] [Abstract][Full Text] [Related]
27. Fixation of Clostridium difficile toxin A and cholera toxin to intestinal brush border membranes from axenic and conventional mice.
Lucas F; Elmer GW; Brot-Laroche E; Corthier G
Infect Immun; 1989 Jun; 57(6):1680-3. PubMed ID: 2785961
[TBL] [Abstract][Full Text] [Related]
28. Adherence of Clostridium difficile spores to Caco-2 cells in culture.
Paredes-Sabja D; Sarker MR
J Med Microbiol; 2012 Sep; 61(Pt 9):1208-1218. PubMed ID: 22595914
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of bile on bacterial invasion of enterocytes: possible mechanism for increased translocation associated with obstructive jaundice.
Wells CL; Jechorek RP; Erlandsen SL
Crit Care Med; 1995 Feb; 23(2):301-7. PubMed ID: 7867356
[TBL] [Abstract][Full Text] [Related]
30. Clostridium difficile-mediated effects on human intestinal epithelia: Modelling host-pathogen interactions in a vertical diffusion chamber.
Jafari NV; Kuehne SA; Minton NP; Allan E; Bajaj-Elliott M
Anaerobe; 2016 Feb; 37():96-102. PubMed ID: 26708704
[TBL] [Abstract][Full Text] [Related]
31. Clostridium difficile Toxin Biology.
Aktories K; Schwan C; Jank T
Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
[TBL] [Abstract][Full Text] [Related]
32. Evolution of the caecal epithelial barrier during Clostridium difficile infection in the mouse.
Heyman M; Corthier G; Lucas F; Meslin JC; Desjeux JF
Gut; 1989 Aug; 30(8):1087-93. PubMed ID: 2504650
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of adhesive factors of Clostridium difficile involved in adhesion to human colonic enterocyte-like Caco-2 and mucus-secreting HT29 cells in culture.
Eveillard M; Fourel V; Barc MC; Kernéis S; Coconnier MH; Karjalainen T; Bourlioux P; Servin AL
Mol Microbiol; 1993 Feb; 7(3):371-81. PubMed ID: 8459765
[TBL] [Abstract][Full Text] [Related]
34. Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro.
Lima AA; Lyerly DM; Wilkins TD; Innes DJ; Guerrant RL
Infect Immun; 1988 Mar; 56(3):582-8. PubMed ID: 3343050
[TBL] [Abstract][Full Text] [Related]
35. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers.
Hecht G; Pothoulakis C; LaMont JT; Madara JL
J Clin Invest; 1988 Nov; 82(5):1516-24. PubMed ID: 3141478
[TBL] [Abstract][Full Text] [Related]
36. Intestinal epithelial damage in sids babies and its similarity to that caused by bacterial toxins in the rabbit.
Kamaras J; Murrell WG
Pathology; 2001 May; 33(2):197-203. PubMed ID: 11358053
[TBL] [Abstract][Full Text] [Related]
37. Caspase and bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro.
Carneiro BA; Fujii J; Brito GA; Alcantara C; Oriá RB; Lima AA; Obrig T; Guerrant RL
Infect Immun; 2006 Jan; 74(1):81-7. PubMed ID: 16368960
[TBL] [Abstract][Full Text] [Related]
38. Toxigenic C. difficile induced inflammatory marker expression by human intestinal epithelial cells is asymmetrical.
Canny G; Drudy D; Macmathuna P; O'farrelly C; Baird AW
Life Sci; 2006 Jan; 78(9):920-5. PubMed ID: 16185718
[TBL] [Abstract][Full Text] [Related]
39. Effects of epidermal growth factor and Clostridium difficile toxin B in a model of mucosal injury.
Lawrence JP; Brevetti L; Obiso RJ; Wilkins TD; Kimura K; Soper R
J Pediatr Surg; 1997 Mar; 32(3):430-3. PubMed ID: 9094010
[TBL] [Abstract][Full Text] [Related]
40. Intestinal epithelial restitution after TcdB challenge and recovery from Clostridium difficile infection in mice with alanyl-glutamine treatment.
Rodrigues RS; Oliveira RA; Li Y; Zaja-Milatovic S; Costa LB; Braga Neto MB; Kolling GL; Lima AA; Guerrant RL; Warren CA
J Infect Dis; 2013 May; 207(10):1505-15. PubMed ID: 23359592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
